Eric K. Rowinsky

Filings by Eric K. Rowinsky span 3 companies, the busiest being Biogen Inc., Fortress Biotech, Inc. and Verastem, Inc. In total, 15 filings cover trades dated from 1 January 2016 to 9 June 2026.

No open-market sale appears; the market trades are 3 purchases worth €110k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 12 share grants.

The median purchase comes to €9,309.

Most recently, on 11 June 2026, the filings show a share grant in Biogen Inc. The clock since the last published purchase (20 February 2024) now reads 971 days. Typically, a trade is published a median of 3 days after it takes place. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.